Internal Medicine News - Generic leflunomide approved
December 1, 2005 -- The generic equivalent of Arava (leflunomide) tablets is now approved. The 10-mg and 20-mg tablets are indicated in adults for the treatment of...
Internal Medicine News - Peripheral neuropathy seen with leflunomide
June 15, 2005 -- BIRMINGHAM, ENGLAND -- Patients taking leflunomide should be monitored for symptoms of new-onset peripheral neuropathy, a retrospective study...
Internal Medicine News - Few women on leflunomide advised to avoid pregnancy
February 15, 2007 -- TUCSON, ARIZ. -- Only 35% of women taking the category X medication leflunomide recall their rheumatologist advising them to avoid pregnancy at the...
Business Wire - Teva Announces Approval of Leflunomide Tablets
September 14, 2005 -- JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval...
Business Wire - Apotex Receives Final Approval for Leflunomide Tablets
September 14, 2005 -- WESTON, Fla. -- Apotex Corp. today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated...
Journal of AOAC International - Spectrophotometric stability-indicating methods for the determination of leflunomide in the presence of its degradates
November 1, 2006 -- Five simple and sensitive methods were developed for the determination of leflunomide (I) in the presence of its degradates 4-trifluoromethyl aniline...
Skin & Allergy News - Infliximab and leflunomide show promise for cutaneous sarcoidosis
June 1, 2005 -- Key Biscayne, Fla. -- Although antimalarial agents are first-line treatment for cutaneous sarcoidosis, infliximab and leflunomide are showing promise...
Internal Medicine News - FDA rejects request to take leflunomide off the market
May 15, 2004 -- The Food and Drug Administration denied a health advocacy group's request to remove the rheumatoid arthritis drug leflunomide from the market,...
Business Wire - Prasco Ships Leflunomide Tablets; Prasco Will Market the Adult Rheumatoid Arthritis Treatment of sanofi-aventis' Arava®; Prasco's Leflunomide Tablets is...
September 14, 2005 -- CINCINNATI -- Prasco Laboratories, a privately held pharmaceutical company located in Cincinnati, Ohio, announced today it has begun shipping its...
Journal of Drugs in Dermatology - Leflunomide as a novel treatment option in severe atopic dermatitis
September 1, 2004 -- The authors set forth a study of two patients with severe atopic dermatitis (AD), recalcitrant for 20 months with leflunomide. At regular visits...
